美国食品和药物管理局批准摘要:Ribociclib与辅助激素受体中的芳酶抑制剂-阳性,人体表皮生长因子受体2-阴性II期和III期高风险早期乳腺癌治疗设置
Jennifer J Gao1, Tatiana M Prowell1, Haley Gittleman1
1US Food and Drug Administration, Silver Spring, MD.
概括
美国FDA批准了 ribociclib 加上一种芳香酶抑制剂用于高风险的早期乳腺癌. 这种组合在NATALEE试验中显著改善了无侵袭性疾病生存率,证明了有利的益处风险概况.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 激素受体阳性 (HR+),人体表皮生长因子受体2 (HER2) 阴性早期乳腺癌 (EBC) 是一个重大的临床挑战.
- 辅助疗法旨在降低高风险EBC患者复发风险.
- 正在不断研究新的治疗策略,以改善EBC患者的治疗结果.
研究的目的:
- 评估与芳香酶抑制剂 (AI) 结合使用的 ribociclib 的疗效和安全性,用于辅助治疗高风险HR+,HER2阴性II期和III期EBC的成年人.
- 确定这种组合对无侵袭性疾病生存率 (iDFS) 和整体生存率 (OS) 的影响.
主要方法:
- NATALEE试验是一项随机的,开放的,多中心的研究,比较了ribociclib加AI与AI单独的HR+,HER2-阴性II/III阶段EBC患者.
- 患者接受了 ribociclib (400 毫克每天一次,3 周/1 周休息) 长达 36 个月,AI 每个标准护理至少 5 年.
- 主要终点是iDFS,OS作为次要终点. 数据使用治疗意图 (ITT) 人口进行分析.
主要成果:
- 在最终分析中,添加 ribociclib 到 AI 显示出 iDFS 的统计学上显著改善,危险比率 (HR) 为 0.75 (95% CI,0.63 到 0.89).
- 在36个月后,ribociclib加AI组的iDFS为90.7%,AI单独组为87.6%.
- 与AI单独组相比,在ribociclib加AI组中观察到所有级别和≥3级别不良反应的更高率.
结论:
- 辅助性 рибоциклиб与芳香酶抑制剂结合,显示出高风险HR+,HER2-阴性II期和III期EBC的成年人有利的益处风险概况.
- 组合治疗导致了在无侵袭性疾病生存率上具有统计学意义的优势.
- 总体生存数据仍未成熟,需要进一步跟进.
相关概念视频
Drug Administration and Therapy Phases: Overview
743
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
743
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Prescription, Nonprescription and Orphan Drugs
845
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
845
Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K


